Enrichment of the pentose phosphate pathway and dermatan sulfate degradation in pRCC type 1, oncometabolite SAICAR in ROs, and proline and NADH, coupled with high PYCR1 expression in non-ccRCC tumors with high wGII warrant further investigations. Here, PYCR1 is linked to nonpapillary renal cell carcinoma.